Results 131 to 140 of about 303,882 (203)

Graves' orbitopathy following Alemtuzumab treatment for multiple sclerosis: a systematic review and real-world insights. [PDF]

Thyroid Res
Patera B, Zaffaroni A, Louka S, Gallo D, Piantanida E, Tanda ML.   +5 more
europepmc   +1 more source

Graves Dermopathy With Delayed Thyrotropin Receptor Antibodies Positivity. [PDF]

JCEM Case Rep
Ribeiro S, Rios E, Vide J, Varela A.
europepmc   +1 more source

Role of interleukin 17 and T helper cells 17 cells as a new immune target and signalling in the pathogenesis and treatment of autoimmune thyroid diseases. [PDF]

Ann Med
He H, Jiang Y, Qiu J, Shen F, Qian D, Meng L.   +5 more
europepmc   +1 more source

Apathetic Thyroid Storm Presenting as New-Onset Dilated Cardiomyopathy and Cardiogenic Shock. [PDF]

Cureus
Bhandari P, Abou-Elmagd T, Pande S, Kandel N, Ncogo Alene I.   +4 more
europepmc   +1 more source

Blink and You'll Miss It: Diagnostic Pitfalls in a Case of Missed Ocular Myasthenia Gravis in the Emergency Department. [PDF]

Cureus
Neumann J, Aqil MS, Singh SP, Fawaz D.
europepmc   +1 more source

Oscillation between Hyperthyroidism and Hypothyroidism in an Adolescent Female with Graves' Disease. [PDF]

J ASEAN Fed Endocr Soc
Lee YL.
europepmc   +1 more source

Higher serum IgG4 levels correlate with better quality of life in mild Graves' orbitopathy: a preliminary report. [PDF]

Endocr Connect
Lin CH, Lee YC, Hsiue YC, Wei YH, Lee CW, Yang CY, Fan KC, Yen IW, Lu C, Huang TY, Lin CH, Shih SR.   +11 more
europepmc   +1 more source

Targeted Thyroid Screening in Patients With Vitiligo: A Practical Narrative Review. [PDF]

Cureus
Naidnur S, Martínez-Ortega JI.
europepmc   +1 more source

Glucocorticoid-Induced Osteoporosis: Pathogenesis, the Impact of Different Administration Routes on Bone Mineral Density, and Fracture Risk and Treatment Options-A Narrative Review. [PDF]

J Clin Med
Kapszewicz M, Michalska-Kasiczak M, Sewerynek E.   +2 more
europepmc   +1 more source